A neurochemical study of developmental impairment of the brain caused by the administration of cytosine arabinoside during the fetal or neonatal period of rats.
Injection of pregnant rats with cytosine arabinoside (ara-C) (280 mg/kg) on day 15 of gestation caused a significant rise (about two times the control value) in monoamine concentrations (norepinephrine, dopamine, and serotonin) accompanied by a decrease (about 60% of the control) in the brain weight and DNA content in the cerebrum of the offspring at 60 days of age. When neonatal rats were injected with ara-C (30 mg/kg/day) for four consecutive days from the fourth to seventh days after birth, a decrease of DNA content per cerebellum and an elevation of monoamine concentrations in the cerebellum were found. However, the total content of each monoamine per cerebrum or cerebellum showed no difference from the control. These results suggest that monoaminergic neurons may remain intact, with normal monoaminergic synapses compressed into a small brain volume. The neonatal administration of ara-C caused an elevation of 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) (EC 3.1.4.37) activity and myelin protein content in the cerebellum, suggesting a relative increase in myelin concentration as a result of hypoplasia of granule cells.
D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000187:drug effects / Q000196:embryology / Q000254:growth & development*; D003561:Cytarabine / Q000633:toxicity*; D004247:DNA / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D005260:Female; D008431:Maternal-Fetal Exchange; D009638:Norepinephrine / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D009928:Organ Specificity; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000378:metabolism
D003561:Cytarabine; D012701:Serotonin; D004247:DNA; D004298:Dopamine; D009638:Norepinephrine